National Advertising Division Says Pre-Launch Investor Presentation Can Be Challenged Under Advertising LawBy: David Bernsteinon January 12, 2021 at 5:15 pm Publication: IPWatchdog.com | Patents & Patent Law

It has long been a fundamental tenet of advertising law that comments made to investors, and particularly those made before the commercial launch of a product or service, do not constitute the kind of “advertising” that is regulated by the Federal Trade Commission (FTC) or the National Advertisi  Read More>>

Categories   Business, Government, Guest Contributors, IP News, IPWatchdog Articles, Trademark, advertising law, Bayer HealthCare, Better Business Bureau, false advertising, Federal Trade Commission, Lanham Act, National Advertising Division, PLx Pharma, Vazalore